Kim Eunhee, Wang Bin, Sastry Namratha, Masliah Eliezer, Nelson Peter T, Cai Huaibin, Liao Francesca-Fang
Department of Pharmacology and Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, 874 Union Avenue/Crowe 401, Memphis, TN 38163, USA.
Transgenics Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Hum Mol Genet. 2016 Jan 15;25(2):211-22. doi: 10.1093/hmg/ddv445. Epub 2015 Oct 26.
Cellular protein homeostasis is achieved by a delicate network of molecular chaperones and various proteolytic processes such as ubiquitin-proteasome system (UPS) to avoid a build-up of misfolded protein aggregates. The latter is a common denominator of neurodegeneration. Neurons are found to be particularly vulnerable to toxic stress from aggregation-prone proteins such as α-synuclein. Induction of heat-shock proteins (HSPs), such as through activated heat shock transcription factor 1 (HSF1) via Hsp90 inhibition, is being investigated as a therapeutic option for proteinopathic diseases. HSF1 is a master stress-protective transcription factor which activates genes encoding protein chaperones (e.g. iHsp70) and anti-apoptotic proteins. However, whether and how HSF1 is dysregulated during neurodegeneration has not been studied. Here, we discover aberrant HSF1 degradation by aggregated α-synuclein (or α-synuclein-induced proteotoxic stress) in transfected neuroblastoma cells. HSF1 dysregulation via α-synuclein was confirmed by in vivo assessment of mouse and in situ studies of human specimens with α-synucleinopathy. We demonstrate that elevated NEDD4 is implicated as the responsible ubiquitin E3 ligase for HSF1 degradation through UPS. Furthermore, pharmacologically induced SIRT1-mediated deacetylation can attenuate aberrant NEDD4-mediated HSF1 degradation. Indeed, we define the acetylation status of the Lys 80 residue located in the DNA-binding domain of HSF1 as a critical factor in modulating HSF1 protein stability in addition to its previously identified role in the transcriptional activity. Together with the finding that preserving HSF1 can alleviate α-synuclein toxicity, this study strongly suggests that aberrant HSF1 degradation is a key neurodegenerative mechanism underlying α-synucleinopathy.
细胞蛋白质稳态是通过分子伴侣的精细网络和各种蛋白水解过程(如泛素-蛋白酶体系统(UPS))实现的,以避免错误折叠的蛋白质聚集体的积累。后者是神经退行性变的一个共同特征。人们发现神经元特别容易受到易聚集蛋白(如α-突触核蛋白)产生的毒性应激的影响。通过抑制Hsp90激活热休克转录因子1(HSF1)来诱导热休克蛋白(HSPs),正作为治疗蛋白病的一种选择进行研究。HSF1是一种主要的应激保护转录因子,可激活编码蛋白伴侣(如诱导型Hsp70)和抗凋亡蛋白的基因。然而,HSF1在神经退行性变过程中是否失调以及如何失调尚未得到研究。在这里,我们发现在转染的神经母细胞瘤细胞中,聚集的α-突触核蛋白(或α-突触核蛋白诱导的蛋白毒性应激)会导致HSF1异常降解。通过对小鼠的体内评估和对患有α-突触核蛋白病的人类标本的原位研究,证实了α-突触核蛋白对HSF1的失调作用。我们证明,NEDD4水平升高与通过UPS导致HSF1降解的泛素E3连接酶有关。此外,药理学诱导的SIRT1介导的去乙酰化可以减弱NEDD4介导的HSF1异常降解。事实上,我们将位于HSF1 DNA结合结构域的赖氨酸80残基的乙酰化状态定义为调节HSF1蛋白稳定性的关键因素,此外它在转录活性中也有先前确定的作用。连同保留HSF1可以减轻α-突触核蛋白毒性这一发现,这项研究有力地表明,HSF1异常降解是α-突触核蛋白病潜在的关键神经退行性机制。